EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Increased body mass index is negatively associated with ovarian reserve as measured by anti‐Müllerian hormone in patients with polycystic ovarian syndrome

Jacqueline Kloos, Jaime Perez, Rachel Weinerman

Clinical Obesity · 2024-06 · 14 (3)

DOI: 10.1111/cob.12638 ↗
AbstractBibliografische Angaben

Abstract

Summary Anti‐Müllerian hormone (AMH) is commonly used as a marker of ovarian reserve. Although obesity is associated with decreased fertility, the relationship between body mass index (BMI) and AMH remains uncertain, hindering the accurate interpretation of AMH. We sought to assess the relationship between serum AMH and BMI in patients with and without polycystic ovarian syndrome (PCOS). This study analysed 500 patients at a single centre between 2020 and 2021. Patients were divided into cohorts: those with BMI 40 kg/m 2 . Patients with and without PCOS were included. Chi‐square tests, Fisher's exact tests, multiple linear regression analysis and independent t ‐tests were performed as appropriate. In the general study population, serum AMH was not significantly different in the BMI >40 kg/m 2 group compared to the BMI

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →